Construction and characterization of E3-deleted bovine adenovirus type 3 expressing full-length and truncated form of bovine herpesvirus type 1 glycoprotein gD
- PMID: 9770436
- DOI: 10.1006/viro.1998.9351
Construction and characterization of E3-deleted bovine adenovirus type 3 expressing full-length and truncated form of bovine herpesvirus type 1 glycoprotein gD
Abstract
Using the homologous recombination machinery of E. coli, a 1.245-kb deletion was introduced in the E3 region of bovine adenovirus 3 (BAV3) genomic DNA cloned in a plasmid. Transfection of the restriction enzyme-excised, linear E3-deleted BAV3 genomic DNA into primary fetal bovine retina cells produced infectious virus (BAV3. E3d), suggesting that all the E3-specific open reading frames are nonessential for virus replication in vitro. Using a similar approach, we constructed replication-competent (BAV3.E3gD and BAV3. E3gDt) BAV3 recombinant expressing full-length (gD) or truncated (gDt) glycoprotein of bovine herpes virus 1. Recombinant gD and gDt proteins expressed by BAV3.E3gD and BAV3.E3gDt, respectively, were recognized by gD-specific monoclonal antibodies directed against conformational epitopes, suggesting that antigenicity of recombinant gD and gDt was similar to that of the native gD expressed in bovine herpes virus 1-infected cells. Intranasal immunization of cotton rats induced strong gD- and BAV3-specific IgA and IgG immune responses. These results suggest that replication-competent bovine adenovirus 3-based vectors have potential for the delivery of vaccine antigens to the mucosal surfaces of animals.
Copyright 1998 Academic Press.
Similar articles
-
Induction of systemic and mucosal immune responses in cotton rats immunized with human adenovirus type 5 recombinants expressing the full and truncated forms of bovine herpesvirus type 1 glycoprotein gD.Virology. 1996 Aug 15;222(2):299-309. doi: 10.1006/viro.1996.0427. Virology. 1996. PMID: 8806514
-
Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1.J Gen Virol. 1999 May;80 ( Pt 5):1263-1269. doi: 10.1099/0022-1317-80-5-1263. J Gen Virol. 1999. PMID: 10355773
-
Mutational analysis of early region 4 of bovine adenovirus type 3.Virology. 2001 Nov 10;290(1):153-63. doi: 10.1006/viro.2001.1176. Virology. 2001. PMID: 11883000
-
Canine adenovirus based rabies vaccines.Dev Biol (Basel). 2008;131:467-76. Dev Biol (Basel). 2008. PMID: 18634509 Review.
-
DNA immunization with bovine herpesvirus-1 genes.Ann N Y Acad Sci. 1995 Nov 27;772:47-63. doi: 10.1111/j.1749-6632.1995.tb44731.x. Ann N Y Acad Sci. 1995. PMID: 8546413 Review. No abstract available.
Cited by
-
Bovine Adenoviral Vector-Based Platform for Vaccine Development.Vaccines (Basel). 2025 May 3;13(5):494. doi: 10.3390/vaccines13050494. Vaccines (Basel). 2025. PMID: 40432106 Free PMC article. Review.
-
Conserved arginines of bovine adenovirus-3 33K protein are important for transportin-3 mediated transport and virus replication.PLoS One. 2014 Jul 14;9(7):e101216. doi: 10.1371/journal.pone.0101216. eCollection 2014. PLoS One. 2014. PMID: 25019945 Free PMC article.
-
Nonhuman Adenoviral Vector-Based Platforms and Their Utility in Designing Next Generation of Vaccines for Infectious Diseases.Viruses. 2021 Jul 29;13(8):1493. doi: 10.3390/v13081493. Viruses. 2021. PMID: 34452358 Free PMC article. Review.
-
Use of adenoviral vectors as veterinary vaccines.Gene Ther. 2005 Oct;12 Suppl 1(Suppl 1):S73-83. doi: 10.1038/sj.gt.3302618. Gene Ther. 2005. PMID: 16231058 Free PMC article. Review.
-
Optimization of bovine coronavirus hemagglutinin-estrase glycoprotein expression in E3 deleted bovine adenovirus-3.Virus Res. 2000 Sep;70(1-2):65-73. doi: 10.1016/s0168-1702(00)00209-4. Virus Res. 2000. PMID: 11074126 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous